Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Phase 1/2 Recruiting
56 enrolled
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 Recruiting
45 enrolled
UFSR for OS
Recruiting
10 enrolled
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Phase 2 Recruiting
60 enrolled
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Phase 2 Recruiting
40 enrolled
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 Recruiting
27 enrolled
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Recruiting
300 enrolled
AflacST2301
Phase 1 Recruiting
12 enrolled
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Phase 1/2 Recruiting
104 enrolled
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Phase 1 Recruiting
24 enrolled
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Phase 1/2 Recruiting
63 enrolled
REGOSTA
Phase NA Recruiting
168 enrolled
REGOMAIN
Phase 2 Recruiting
36 enrolled
Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Phase 1 Recruiting
30 enrolled
Pediatric PET/MR Image Registry
Recruiting
100 enrolled
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 Recruiting
90 enrolled
GISAR
Recruiting
9,000 enrolled
PREMOST
Recruiting
40 enrolled
Losartan + Sunitinib in Treatment of Osteosarcoma
Phase 1 Recruiting
41 enrolled
ADER
Recruiting
50 enrolled
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Phase 1 Recruiting
25 enrolled
Aflac-NBL-2002
Phase 1 Recruiting
24 enrolled
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Phase 1 Recruiting
30 enrolled
MAST
Recruiting
1,000 enrolled
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Phase 1 Recruiting
44 enrolled
Indocyanine Green (ICG) Guided Tumor Resection
Phase 1 Recruiting
230 enrolled
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 Recruiting
32 enrolled
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Phase 1 Recruiting
22 enrolled
OSTEO LR
Recruiting
150 enrolled
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Phase 1 Recruiting
18 enrolled
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 Recruiting
86 enrolled
Clinical Orthopaedic Data Bank (Acute and Chronic)
Recruiting
10,000 enrolled
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Phase 2 Recruiting
44 enrolled
BAH2573-103
Phase 1/2 Recruiting
60 enrolled
Early Ageing During Therapy in AYA Cancer Patients
Recruiting
120 enrolled
Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
Recruiting
30 enrolled
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Phase 1 Recruiting
24 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
ROLN-B7-H3
Phase 1/2 Recruiting
32 enrolled
Osteomyc
Phase 2 Recruiting
10 enrolled
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
Phase 2 Recruiting
30 enrolled
P1V2
Phase NA Recruiting
106 enrolled
Cytalux
Phase 1 Recruiting
10 enrolled
ICONIC
Recruiting
300 enrolled
A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma
Phase 2 Recruiting
160 enrolled
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Phase 2/3 Recruiting
50 enrolled
PROMIS
Phase 2 Recruiting
43 enrolled
PRIMA
Phase 2 Recruiting
86 enrolled
ProFertil
Phase 3 Recruiting
500 enrolled